Immunotherapy: Cancer Care Gets Customized

Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics.      Tiffani A. DeMarco, MS, CGC, is a board-certified…

Read More

Inova Personalized Health Accelerator Launches New Entrepreneur Education Program

inova logo

Health System Driving Innovation by Developing the Next Generation of Healthcare Technology Entrepreneurs Fairfax, VA – The Inova Personalized Health Accelerator (IPHA) announced today that it is launching a free educational program designed for first-time healthcare technology entrepreneurs. The program is designed to provide entrepreneurs with a comprehensive set of skills required to execute the commercialization…

Read More

Inova Center for Personalized Health Announces Forum on Policy and Ethics Issues in Precision Medicine on Sept. 8

inova logo

Fairfax, VA –  Inova Center for Personalized Health (ICPH) announced today it will host the first-ever Precision Medicine Policy and Ethics Conference on Sept. 8, 2017 at  Inova Center for Personalized Health in Fairfax, Va. The conference is a forum for national and industry leaders to address the most pressing challenges in the clinical adoption…

Read More

Shenandoah University and Inova Partner to Educate the Healthcare Workforce of the Future

inova logo

Inova Center For Personalized Health To House Programs Winchester, Va. (April 3, 2017) – Shenandoah University and Inova announced today a collaborative partnership to educate the next generation of healthcare professionals with an emphasis on population health, pharmacogenomics, and other new healthcare technologies. The partnership builds upon the individual strengths of Inova and Shenandoah and…

Read More

Inova and the FNIH Biomarkers Consortium Launch Public-Private Partnership to Develop Novel Imaging Methods to More Accurately Measure Cancer Response and Progression

inova logo

FALLS CHURCH, VA – Inova, in coordination with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, is launching a three-year research partnership to develop new methods for analyzing digital images that track a patient’s response to cancer therapy. Michael Maitland, MD, PhD, Director of Therapeutics for the Inova Center for Personalized Health…

Read More